Table 1—

Clinical characteristics and baseline laboratory data of the control and intervention groups

CharacteristicsControl groupIntervention groupP
n5555
Age (years)54.7 ± 9.453.5 ± 8.80.507
Sex (M/F)32/1835/160.623
BMI (kg/m2)23.9 ± 3.124.4 ± 3.40.493
Diabetes duration (years)6.6 ± 5.77.0 ± 6.30.751
Diagnosis of hypertension (n)13170.420
Systolic blood pressure (mmHg)128.5 ± 17.0124.7 ± 15.80.999
Diastolic blood pressure (mmHg)77.0 ± 9.777.5 ± 8.70.254
HbA1c (%)7.19 ± 1.177.59 ± 1.430.133
Fasting plasma glucose (mg/dl)136.4 ± 32.3136.0 ± 35.00.826
Total cholesterol (mg/dl)180.9 ± 28.9188.8 ± 30.100.231
Triglyceride (mg/dl)136.8 ± 94.0154.7 ± 98.10.358
HDL (mg/dl)47.9 ± 13.247.7 ± 11.00.925
Blood urea nitrogen (mg/dl)16.2 ± 5.215.2 ± 3.80.393
Creatinine (mg/dl)0.9 ± 0.30.9 ± 0.20.498
  • Data are means ± SD.